Schedule 13D ownership disclosure

LogicBio Therapeutics, Inc.

Security class unavailable · CUSIP: 54142F102

Event date: 2022-04-21

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
5.5700%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-22-140534
Form type
SC 13D/A
Filer
Arix Bioscience plc
CIK
CIK 1700449
Filed
May 04, 2022
Reporting period
Apr 21, 2022
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub